Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Danyi Tablet is a Traditional Chinese Medicine (TCM) formulation developed by the Second Affiliated Hospital of Tianjin University of TCM for the treatment of chronic prostatitis. It is specifically indicated for patients presenting with the TCM pattern of 'static blood obstructing and dampness-heat pouring down.' The formulation typically aims to promote blood circulation, resolve stasis, and clear heat and dampness. It has been evaluated in clinical trials comparing its efficacy and safety against other TCM treatments like Qianlietai granules.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Danyi Tablet (Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine).